Children's Advil Ad Ban Is Proper, J&J Unit Tells 2nd. Circ.

Law360, New York (January 11, 2017, 1:26 PM EST) -- A New York federal judge was right to find a decades-old order stopping Pfizer from promoting Advil’s risk of stomach damage as comparable to Tylenol’s also applies to Children’s Advil because the order focuses on the drug itself, not the brand, a Johnson & Johnson unit told the Second Circuit on Tuesday.

U.S. District Judge Andrew L. Carter’s April decision in favor of Tylenol-maker McNeil-PPC Inc. — now Johnson & Johnson Consumer Inc. — should be upheld because U.S. District Judge William C. Conner’s 1989 order...
To view the full article, register now.

Documents

Related

Sections

Case Information

Case Title

Pfizer Inc. v. McNeil-PPC, Inc.


Case Number

16-1743

Court

Appellate - 2nd Circuit

Nature of Suit

3890 STATUTES-Other

Date Filed

May 31, 2016

Law Firms

Companies

Government Agencies

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.